Rupali Jain

1.5k total citations
55 papers, 1.1k citations indexed

About

Rupali Jain is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Rupali Jain has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 22 papers in Epidemiology and 15 papers in Pharmacology. Recurrent topics in Rupali Jain's work include Antibiotic Use and Resistance (15 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Bacterial Identification and Susceptibility Testing (11 papers). Rupali Jain is often cited by papers focused on Antibiotic Use and Resistance (15 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Bacterial Identification and Susceptibility Testing (11 papers). Rupali Jain collaborates with scholars based in United States, South Africa and Belgium. Rupali Jain's co-authors include Larry H. Danziger, Paul S. Pottinger, Robert M. Rakita, David N. Fredricks, Shahin Hakimian, Ayesha Appa, Helen Y. Chu, Hu Xie, Samuel L Aitken and John B. Lynch and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Allergy and Clinical Immunology.

In The Last Decade

Rupali Jain

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rupali Jain United States	17	419	412	335	322	144	55	1.1k
Giammarco Raponi Italy	18	342 0.8×	276 0.7×	343 1.0×	231 0.7×	137 1.0×	81	969
Jin-Won Chung South Korea	18	446 1.1×	526 1.3×	333 1.0×	151 0.5×	156 1.1×	70	1.2k
Wolfgang A. Krueger Germany	21	552 1.3×	317 0.8×	315 0.9×	345 1.1×	176 1.2×	44	1.5k
Béatrice Grabein Germany	14	425 1.0×	255 0.6×	263 0.8×	261 0.8×	124 0.9×	42	921
B. Pilmis France	20	498 1.2×	339 0.8×	324 1.0×	156 0.5×	156 1.1×	85	1.1k
Kei Kasahara Japan	18	499 1.2×	525 1.3×	151 0.5×	249 0.8×	82 0.6×	98	1.3k
Maristela Pinheiro Freire Brazil	23	511 1.2×	189 0.5×	545 1.6×	263 0.8×	168 1.2×	71	1.3k
Alice J. Hsu United States	18	402 1.0×	301 0.7×	453 1.4×	358 1.1×	218 1.5×	41	1.0k
Murat Dizbay Türkiye	20	385 0.9×	393 1.0×	318 0.9×	161 0.5×	98 0.7×	84	1.1k
Jan G. den Hollander Netherlands	16	473 1.1×	289 0.7×	371 1.1×	477 1.5×	106 0.7×	32	1.2k

Countries citing papers authored by Rupali Jain

Since Specialization

Citations

This map shows the geographic impact of Rupali Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupali Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupali Jain more than expected).

Fields of papers citing papers by Rupali Jain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupali Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupali Jain. The network helps show where Rupali Jain may publish in the future.

Co-authorship network of co-authors of Rupali Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Rupali Jain. A scholar is included among the top collaborators of Rupali Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupali Jain. Rupali Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hasegawa, Shinya, et al.. (2024). Characterizing Ertapenem Neurotoxicity: A Systematic Review and Experience at a Tertiary Medical Center. Open Forum Infectious Diseases. 11(5). ofae214–ofae214. 1 indexed citations

Chan, Jeannie D., et al.. (2024). Antimicrobial stewardship and quality improvement strategies in critical access hospitals: a process evaluation of an intensive quality improvement cohort. SHILAP Revista de lepidopterología. 4(1). e201–e201. 1 indexed citations

Park, Sung Sup, Sasan Mirfakhraee, & Rupali Jain. (2024). 674 Single-center experience of effect of glucagon-like-peptide-1 receptor agonists in adults with cystic fibrosis. Journal of Cystic Fibrosis. 23. S377–S377. 1 indexed citations

Moore, Elizabeth A., Rupali Jain, Jeannie D. Chan, et al.. (2024). Qualitative Evaluation of an Antimicrobial Stewardship Tele-Mentoring Program in US Rural & Critical Access Hospitals. SHILAP Revista de lepidopterología. 4(S1). s58–s59.

Chan, Jeannie D., Jehan Z Budak, Shireesha Dhanireddy, et al.. (2023). Antibiotic prescribing patterns for bacterial superinfection of mpox: A retrospective cohort study in an urban center. SHILAP Revista de lepidopterología. 3(1). e108–e108. 3 indexed citations

Tverdek, Frank, et al.. (2023). Antimicrobials in patients with hematologic malignancies and recipients of hematopoietic cell transplantation and other cellular therapies. Transplant Infectious Disease. 25(S1). e14129–e14129.

Nagel, Jerod, et al.. (2023). 1015. A multicenter evaluation of antimicrobial utilization in hospitalized bone marrow transplant (BMT) and T-cell therapy (CAR-T) patients, and the impact on rates of C. difficile infection (CDI). Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Bryson‐Cahn, Chloe, et al.. (2023). Asymptomatic bacteriuria in critical-access hospitals: Prevalence and patient characteristics driving treatment. Infection Control and Hospital Epidemiology. 45(3). 380–383. 4 indexed citations

Macdonald, Barbara, Rupali Jain, Chloe Bryson‐Cahn, et al.. (2022). Prevalence and treatment of asymptomatic bacteriuria at academic and critical-access hospitals—Opportunities for stewardship efforts. Infection Control and Hospital Epidemiology. 44(6). 979–981. 7 indexed citations

10.

Lynch, John B., Paul S. Pottinger, Carolyn Chu, et al.. (2021). 860. HIV Post-exposure Prophylaxis Availability at Small and Critical Access Hospitals in the Western Region. Open Forum Infectious Diseases. 8(Supplement_1). S521–S522. 1 indexed citations

11.

Stewart, Jenell, Rupali Jain, Andrew Bryan, et al.. (2018). Transplant tourism complicated by life-threatening New Delhi metallo-β-lactamase-1 infection. American Journal of Transplantation. 19(4). 1224–1228. 5 indexed citations

12.

Pergam, Steven A., et al.. (2018). Unintended Consequences of Pretransplant Vancomycin-Resistant Enterococcus Screening on Antimicrobial Stewardship Among Allogeneic Hematopoietic Cell Transplant Recipients. Infection Control and Hospital Epidemiology. 39(6). 730–733. 7 indexed citations

13.

Nakagawa, Ryuji, et al.. (2017). Optimization of antimicrobial therapy in vancomycin-resistant enterococcal bacteraemia using a rapid detection Gram-positive blood culture assay. Journal of Hospital Infection. 99(2). 153–157. 4 indexed citations

14.

Munita, José M., Samuel L Aitken, William R. Miller, et al.. (2017). Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa. Clinical Infectious Diseases. 65(1). 158–161. 106 indexed citations

15.

Jain, Rupali, et al.. (2017). Electronic Surveillance For Catheter-Associated Urinary Tract Infection Using Natural Language Processing.. PubMed. 2017. 1507–1516. 11 indexed citations

16.

Chemaly, Roy F., Samuel L Aitken, Cameron R. Wolfe, Rupali Jain, & Michael Boeckh. (2016). Aerosolized ribavirin: the most expensive drug for pneumonia. Transplant Infectious Disease. 18(4). 634–636. 41 indexed citations

17.

Johnston, Christine, Robert Harrington, Rupali Jain, et al.. (2015). Safety and Efficacy of Combination Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Adults Undergoing Autologous or Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 22(1). 149–156. 20 indexed citations

18.

Castilla, Diego López de, Robert M. Rakita, Christopher Spitters, et al.. (2013). Short-Course Isoniazid Plus Rifapentine Directly Observed Therapy for Latent Tuberculosis in Solid-Organ Transplant Candidates. Transplantation. 97(2). 206–211. 26 indexed citations

19.

Jain, Rupali, Christopher Schriever, Larry H. Danziger, Sang‐Hyun Cho, & Israel Rubinstein. (2007). The IS<i>6110</i> Repetitive DNA Element of <i>Mycobacterium tuberculosis</i> Is Not Detected in Exhaled Breath Condensate of Patients with Active Pulmonary Tuberculosis. Respiration. 74(3). 329–333. 17 indexed citations

20.

Jain, Rupali & Larry H. Danziger. (2004). Multidrug-Resistant Acinetobacter Infections: An Emerging Challenge to Clinicians. Annals of Pharmacotherapy. 38(9). 1449–1459. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact